Global network analysis in Schizosaccharomyces pombe reveals three distinct consequences of the common 1-kb deletion causing juvenile CLN3 disease
- PMID: 33737578
- PMCID: PMC7973434
- DOI: 10.1038/s41598-021-85471-4
Global network analysis in Schizosaccharomyces pombe reveals three distinct consequences of the common 1-kb deletion causing juvenile CLN3 disease
Erratum in
-
Author Correction: Global network analysis in Schizosaccharomyces pombe reveals three distinct consequences of the common 1-kb deletion causing juvenile CLN3 disease.Sci Rep. 2021 Jul 5;11(1):14198. doi: 10.1038/s41598-021-93446-8. Sci Rep. 2021. PMID: 34226631 Free PMC article. No abstract available.
Abstract
Juvenile CLN3 disease is a recessively inherited paediatric neurodegenerative disorder, with most patients homozygous for a 1-kb intragenic deletion in CLN3. The btn1 gene is the Schizosaccharomyces pombe orthologue of CLN3. Here, we have extended the use of synthetic genetic array (SGA) analyses to delineate functional signatures for two different disease-causing mutations in addition to complete deletion of btn1. We show that genetic-interaction signatures can differ for mutations in the same gene, which helps to dissect their distinct functional effects. The mutation equivalent to the minor transcript arising from the 1-kb deletion (btn1102-208del) shows a distinct interaction pattern. Taken together, our results imply that the minor 1-kb deletion transcript has three consequences for CLN3: to both lose and retain some inherent functions and to acquire abnormal characteristics. This has particular implications for the therapeutic development of juvenile CLN3 disease. In addition, this proof of concept could be applied to conserved genes for other mendelian disorders or any gene of interest, aiding in the dissection of their functional domains, unpacking the global consequences of disease pathogenesis, and clarifying genotype-phenotype correlations. In doing so, this detail will enhance the goals of personalised medicine to improve treatment outcomes and reduce adverse events.
Conflict of interest statement
The authors declare no competing interests.
Figures






Similar articles
-
btn1, the Schizosaccharomyces pombe homologue of the human Batten disease gene CLN3, regulates vacuole homeostasis.J Cell Sci. 2005 Dec 1;118(Pt 23):5525-36. doi: 10.1242/jcs.02656. Epub 2005 Nov 15. J Cell Sci. 2005. PMID: 16291725
-
Deletion of btn1, an orthologue of CLN3, increases glycolysis and perturbs amino acid metabolism in the fission yeast model of Batten disease.Mol Biosyst. 2010 Jun;6(6):1093-102. doi: 10.1039/b915670d. Epub 2010 Mar 17. Mol Biosyst. 2010. PMID: 20485751
-
A function retained by the common mutant CLN3 protein is responsible for the late onset of juvenile neuronal ceroid lipofuscinosis.Hum Mol Genet. 2008 Jan 15;17(2):303-12. doi: 10.1093/hmg/ddm306. Epub 2007 Oct 18. Hum Mol Genet. 2008. PMID: 17947292
-
Mutated genes in juvenile and variant late infantile neuronal ceroid lipofuscinoses encode lysosomal proteins.Curr Mol Med. 2002 Aug;2(5):439-44. doi: 10.2174/1566524023362311. Curr Mol Med. 2002. PMID: 12125809 Review.
-
Neuronal ceroid lipofuscinoses: research update.Neurol Sci. 2000;21(3 Suppl):S49-56. doi: 10.1007/s100720070040. Neurol Sci. 2000. PMID: 11073228 Review.
Cited by
-
CLN3 transcript complexity revealed by long-read RNA sequencing analysis.BMC Med Genomics. 2024 Oct 4;17(1):244. doi: 10.1186/s12920-024-02017-z. BMC Med Genomics. 2024. PMID: 39367445 Free PMC article.
-
Lysosomal alterations and decreased electrophysiological activity in CLN3 disease patient-derived cortical neurons.Dis Model Mech. 2022 Dec 1;15(12):dmm049651. doi: 10.1242/dmm.049651. Epub 2022 Dec 13. Dis Model Mech. 2022. PMID: 36453132 Free PMC article.
-
PomBase: a Global Core Biodata Resource-growth, collaboration, and sustainability.Genetics. 2024 May 7;227(1):iyae007. doi: 10.1093/genetics/iyae007. Genetics. 2024. PMID: 38376816 Free PMC article. Review.
-
Autophagy in the Neuronal Ceroid Lipofuscinoses (Batten Disease).Front Cell Dev Biol. 2022 Feb 16;10:812728. doi: 10.3389/fcell.2022.812728. eCollection 2022. Front Cell Dev Biol. 2022. PMID: 35252181 Free PMC article. Review.
-
Cerebrospinal Fluid Protein Biomarker Discovery in CLN3.J Proteome Res. 2023 Jul 7;22(7):2493-2508. doi: 10.1021/acs.jproteome.3c00199. Epub 2023 Jun 20. J Proteome Res. 2023. PMID: 37338096 Free PMC article.
References
-
- Mole SE, Anderson G, Band HA, Berkovic SF, Cooper JD, Kleine Holthaus S-M, Mckay TR, Medina DL, Rahim AA, Schulz A, Smith AJ. Clinical challenges and future therapeutic approaches for neuronal ceroid lipofuscinosis. Lancet Neurol. 2019;18:107–116. - PubMed
-
- Mitchison HM, Munroe PB, O’rawe AM, Taschner PE, De Vos N, Kremmidiotis G, Lensink I, Munk AC, D’arigo KL, Anderson JW, Lerner TJ, Moyzis RK, Callen DF, Breuning MH, Doggett NA, Gardiner RM, Mole SE. Genomic structure and complete nucleotide sequence of the batten disease gene, CLN3. Genomics. 1997;40:346–350. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources